Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Ahmad Masri et al.|The Lancet|2020Cited by 1.2k
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryAlida L.P. Caforio, Klaudia Vivien Nagy, Juan Pablo Kaski et al.|European Heart Journal|2024Cited by 35